William Guilmain - Concepedia

Author

William Guilmain

Lund University

Also Known As

W Guilmain, W. Guilmain, William Guilmain

Publications

302

Citations

H-Index

Concepts

All Affiliations

Lund University Centre National de la Recherche Scientifique Dr. Hari Singh Gour University Skåne University Hospital

About

William Guilmain is an author at Lund University specializing in medicine, cell biology, and metabolic signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	129
2	Cell Biology	2	2	73
3	Engineering	1	1	56
4	Health Sciences	1	1	48
5	Biomedical Engineering	1	1	56

William Guilmain

Publications

296

Citations

H-Index

Page 1

	Year	Citations
WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition Chandra Prakash Prasad, Shivendra K. Chaurasiya, William Guilmain, Journal of Experimental & Clinical Cancer Research	2016	64
Dual-Specificity Phosphatase 3 Deficiency or Inhibition Limits Platelet Activation and Arterial Thrombosis Lucia Musumeci, Marijke J. E. Kuijpers, Karen Gilio, Circulation	2014	58
Enhanced Achilles tendon healing by fibromodulin gene transfer Anthony Delalande, Marie‐Pierre Gosselin, Arnaud Suwalski, Nanomedicine Nanotechnology Biology and Medicine MechanobiologyRegenerative MedicineSoft Tissue InjuryMusculoskeletal ResearchEngineering	2015	56
WNT5A-mediated -catenin-independent signalling is a novel regulator of cancer cell metabolism Victoria Sherwood, Shivendra K. Chaurasiya, Elin Ekström, Carcinogenesis Cancer Cell MetabolismMetabolic RemodelingWnt5a SignallingCancer BiologyTumor Biology	2013	48
Overexpression of CD39 in Mouse Airways Promotes Bacteria-Induced Inflammation Emilie Théâtre, Kim Frederix, William Guilmain, The Journal of Immunology AsthmaInflammationCytokineInflammatory Lung DiseaseLung Inflammation	2012	25
CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth William Guilmain, S Cooper Colin, E Legrand, British Journal of Cancer	2011	24
A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth S Cooper Colin, William Guilmain, Estelle Creoff, British Journal of Cancer	2011	21

Page 1